ARCHIVES

CMS Launches National Coverage Analysis, Citing FDA’s Black Box Warning on ESAs.

This article is from The Cancer Letter archive.

Vol. 33 No. 10 | March 16, 2007

Download PDF Visit The Full Archive

Related Articles

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

NCAB Defends Organ Site Program, But DeVita Still Plan to Discuss It With Cancer Panel

October 17, 1980

DRCCA Board, Subcommittee Approve Reorganization Of Education Program

February 5, 1982

President’s Budget: $64 Million Cut for NCI, No Start On Year 2000 goals, Drop 240 Grants In 1985

February 8, 1985

FDA Approves Votrient For Renal Cell Carcinoma

October 23, 2009

Coffey Presses NCI BSA chairman David Linvingston On support For Increase In NCI Budget

April 25, 1997